Overview
- The Pentagon announced the program on Wednesday, adding annual testosterone screening to routine medical exams for service members aged 30 and older while making testing optional for younger personnel.
- Secretary Pete Hegseth said the effort is meant to restore natural capacity and protect readiness and longevity, and he emphasized that any recommended testosterone replacement therapy would be voluntary.
- The Defense Department has not yet specified key clinical and operational details such as normal hormone ranges, requirement for morning confirmatory tests, eligibility criteria for treatment, medical-record handling, or whether low results could affect deployability or assignments.
- Major medical societies recommend testing only for people with symptoms and require at least two separate morning measurements, so clinicians warn that broad, symptom-free screening could create many borderline or transient low readings and risk unnecessary treatment.
- The change builds on prior concerns about performance‑related substances in elite units and parallels administration efforts to ease access to testosterone, prompting questions about equity for women, noncombat personnel, and how the military will manage follow-up care.